The Ecstasy and Related Drugs Reporting System (EDRS) is an illicit drug monitoring system which has been conducted in all states and territories of Australia since 2003, and forms part of Drug Trends.
In 2022, we have provided a suite of products with the most up-to-date findings from interviews conducted annually from 2003 to 2022 with a cross-sectional sentinel group of people who regularly use ecstasy and other stimulants recruited from all capital cities of Australia.
This includes:
- A report overviewing the key findings in 2022;
- An infographic summarising key findings in 2022;
- A methods document highlighting approaches to collating and presenting estimates; and
- The executive summary, summarising key findings in 2022.
Results are not representative of all consumers or drug use in the general population and should be interpreted alongside findings from other data sources for a more complete profile of emerging trends in illicit drug use in Australia.
Latest release date
21 September 2022
Use of the data
Please note that any presentation of these data should include acknowledgment of Drug Trends at the National Drug and Alcohol Research Centre, University of New South Wales.
Citation: Sutherland, R., Karlsson, A., King, C., Jones, F., Uporova, J., Price, O., Gibbs, D., Bruno, R., Dietze, P., Lenton, S., Salom, C., Grigg, J., Wilson, Y., Wilson, J., Daly, C., Thomas, N., Juckel, J., Degenhardt, L., Farrell, M. & Peacock, A. (2022). Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.
Funding
Drug Trends is supported by funding from the Australian Government Department of Health and Aged Care under the Drug and Alcohol Program.
Queries
Please contact the research team at drugtrends@unsw.edu.au with any queries; to request additional analyses using these data; or to discuss the possibility of including items in future EDRS interviews.